An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-t mri in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator

Pierpaolo Lupo, Riccardo Cappato, Giovanni Di Leo, Francesco Secchi, Giacomo D.E. Papini, Sara Foresti, Hussam Ali, Guido M.G. De Ambroggi, Antonio Sorgente, Gianluca Epicoco, Paola M. Cannaò, Francesco Sardanelli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD). Methods We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG). Results 142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three–12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/ voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic. Conclusions A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.

Original languageEnglish
Pages (from-to)2406-2416
Number of pages11
JournalEuropean Radiology
Volume28
Issue number6
DOIs
Publication statusPublished - Jan 9 2018

Fingerprint

Implantable Defibrillators
Artifacts
Prospective Studies
Safety
Equipment and Supplies
Electric Impedance
Necrosis
Thorax
Odds Ratio
Communication
X-Rays

Keywords

  • Conventional implantable cardioverter defibrillators
  • Conventional pacemakers
  • Image artefacts
  • Magnetic resonance imaging
  • Risk-benefit ratio

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-t mri in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator. / Lupo, Pierpaolo; Cappato, Riccardo; Di Leo, Giovanni; Secchi, Francesco; Papini, Giacomo D.E.; Foresti, Sara; Ali, Hussam; De Ambroggi, Guido M.G.; Sorgente, Antonio; Epicoco, Gianluca; Cannaò, Paola M.; Sardanelli, Francesco.

In: European Radiology, Vol. 28, No. 6, 09.01.2018, p. 2406-2416.

Research output: Contribution to journalArticle

@article{cf223e5b98b3450181378ccee10c23e7,
title = "An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-t mri in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator",
abstract = "Objectives To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD). Methods We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG). Results 142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three–12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/ voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic. Conclusions A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.",
keywords = "Conventional implantable cardioverter defibrillators, Conventional pacemakers, Image artefacts, Magnetic resonance imaging, Risk-benefit ratio",
author = "Pierpaolo Lupo and Riccardo Cappato and {Di Leo}, Giovanni and Francesco Secchi and Papini, {Giacomo D.E.} and Sara Foresti and Hussam Ali and {De Ambroggi}, {Guido M.G.} and Antonio Sorgente and Gianluca Epicoco and Canna{\`o}, {Paola M.} and Francesco Sardanelli",
year = "2018",
month = "1",
day = "9",
doi = "10.1007/s00330-017-5098-z",
language = "English",
volume = "28",
pages = "2406--2416",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-t mri in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator

AU - Lupo, Pierpaolo

AU - Cappato, Riccardo

AU - Di Leo, Giovanni

AU - Secchi, Francesco

AU - Papini, Giacomo D.E.

AU - Foresti, Sara

AU - Ali, Hussam

AU - De Ambroggi, Guido M.G.

AU - Sorgente, Antonio

AU - Epicoco, Gianluca

AU - Cannaò, Paola M.

AU - Sardanelli, Francesco

PY - 2018/1/9

Y1 - 2018/1/9

N2 - Objectives To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD). Methods We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG). Results 142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three–12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/ voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic. Conclusions A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.

AB - Objectives To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD). Methods We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG). Results 142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three–12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/ voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic. Conclusions A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.

KW - Conventional implantable cardioverter defibrillators

KW - Conventional pacemakers

KW - Image artefacts

KW - Magnetic resonance imaging

KW - Risk-benefit ratio

UR - http://www.scopus.com/inward/record.url?scp=85040233659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040233659&partnerID=8YFLogxK

U2 - 10.1007/s00330-017-5098-z

DO - 10.1007/s00330-017-5098-z

M3 - Article

C2 - 29318430

AN - SCOPUS:85040233659

VL - 28

SP - 2406

EP - 2416

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 6

ER -